NCT04089176View on ClinicalTrials.gov

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 30, 2019

Study Completion Date

May 31, 2019

Conditions

Postpartum HemorrhageCesarean SectionHigh Risk Pregnancy

Interventions

DRUG

Carbetocin

carbetocin 100 mcg + RLS solution 10 ml injected directly into the vein over 2 min

DRUG

oxytocin

oxytocin 20 IU diluted in 1000 ml of RLS solution administered intravenously at rate 120 ml/hr x 8 hr

Trial Locations (1)

10400

Rajavithi Hospital, Bangkok

All Listed Sponsors

lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT04089176 - Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH | Biotech Hunter | Biotech Hunter